|
US20040176358A1
(en)
*
|
1999-04-30 |
2004-09-09 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
|
CA2372150C
(en)
*
|
1999-04-30 |
2011-08-30 |
The Regents Of The University Of Michigan |
Therapeutic applications of pro-apoptotic benzodiazepines
|
|
US20060025388A1
(en)
|
1999-04-30 |
2006-02-02 |
Glick Gary D |
Compositions and methods relating to novel compounds and targets thereof
|
|
US20050113460A1
(en)
*
|
1999-04-30 |
2005-05-26 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
|
US20030119029A1
(en)
*
|
1999-04-30 |
2003-06-26 |
Regents Of The University Of Michigan |
Compositions and methods relating to novel benzodiazepine compounds and targets thereof
|
|
US7572788B2
(en)
|
1999-04-30 |
2009-08-11 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
|
US20050272723A1
(en)
*
|
2004-04-27 |
2005-12-08 |
The Regents Of The University Of Michigan |
Methods and compositions for treating diseases and conditions associated with mitochondrial function
|
|
US20060052369A1
(en)
*
|
2004-09-07 |
2006-03-09 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
|
WO2006074358A1
(en)
*
|
2005-01-03 |
2006-07-13 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
|
JP2008545757A
(ja)
|
2005-06-01 |
2008-12-18 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
溶媒和されていないベンゾジアゼピン組成物および方法
|
|
US20070105844A1
(en)
*
|
2005-10-26 |
2007-05-10 |
Regents Of The University Of Michigan |
Therapeutic compositions and methods
|
|
CA2628193C
(en)
|
2005-11-01 |
2012-08-14 |
The Regents Of The University Of Michigan |
Novel 1,4-benzodiazepine-2,5-diones with therapeutic properties
|
|
US7759338B2
(en)
*
|
2006-04-27 |
2010-07-20 |
The Regents Of The University Of Michigan |
Soluble 1,4 benzodiazepine compounds and stable salts thereof
|
|
EP2418206A3
(en)
|
2006-06-09 |
2012-06-27 |
The Regents of the University of Michigan |
Benzodiazepine derivatives useful in the treatment of autoimmune disorders
|
|
US7851465B2
(en)
|
2007-03-09 |
2010-12-14 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
|
WO2009036175A2
(en)
|
2007-09-14 |
2009-03-19 |
The Regents Of The University Of Michigan |
F1f0-atpase inhibitors and related methods
|
|
KR20100083819A
(ko)
|
2007-11-06 |
2010-07-22 |
더 리젠츠 오브 더 유니버시티 오브 미시간 |
피부 병태의 치료에 유용한 벤조디아제피논 화합물
|
|
AU2009291632B2
(en)
|
2008-09-11 |
2013-04-04 |
The Regents Of The University Of Michigan |
Aryl guanidine F1F0-ATPase inhibitors and related methods
|
|
WO2010121164A2
(en)
|
2009-04-17 |
2010-10-21 |
The Regents Of The University Of Michigan |
1,4-benzodiazepinone compounds and their use in treating cancer
|
|
WO2011035124A1
(en)
|
2009-09-18 |
2011-03-24 |
The Regents Of The University Of Michigan |
Benzodiazepinone compounds and methods of treatment using same
|
|
US9126978B2
(en)
|
2009-11-17 |
2015-09-08 |
The Regents Of The University Of Michigan |
1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
|
|
JP5856064B2
(ja)
|
2009-11-17 |
2016-02-09 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
治療特性を有する1,4−ベンゾジアゼピン−2,5−ジオンおよび関連化合物
|